• Profile
Close

Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: A 9-year experience in a tertiary-care paediatric hospital setting

Clinical & Experimental Allergy Oct 24, 2019

Liccioli G, Mori F, Parronchi P, et al. - Given the lack of data on the incidence, triggers, and treatment of severe cutaneous adverse reactions (SCARs) from large-scale epidemiological investigations in the pediatric population, researchers gathered epidemiological, clinical and etiological data from children with SCARs who were referred to their tertiary-care paediatric hospital of Florence. Overall, 54 children, with a median age of 6.5 years, and 31 males, 23 females, were enrolled. In hospitalized children, the incidence of SCARs was estimated to be 0.32% during a 9-year time frame. The reported incidence of SCARs was in line with literature data. Drug allergy investigations were performed on 28 patients and 50% of them resulted positive. Most commonly, drugs were documented as the chief cause. As far as the management of SCARs was concerned, a need for cooperation among professional figures was realized for an early diagnosis and a prompt treatment. Children seemed to have a lower mortality rate.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay